News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
179,818 Results
Type
Article (17404)
Company Profile (18)
Press Release (162395)
Multimedia
Podcasts (21)
Webinars (9)
Section
Business (52049)
Career Advice (381)
Deals (8644)
Drug Delivery (51)
Drug Development (30715)
Employer Resources (38)
FDA (4812)
Job Trends (4576)
News (94202)
Policy (8482)
Tag
Academia (1029)
Accelerated approval (6)
Adcomms (14)
Allergies (43)
Alliances (12668)
ALS (55)
Alzheimer's disease (1077)
Antibody-drug conjugate (ADC) (82)
Approvals (4772)
Artificial intelligence (144)
Autoimmune disease (21)
Automation (8)
Bankruptcy (61)
Best Places to Work (3706)
BIOSECURE Act (8)
Biosimilars (42)
Biotechnology (11)
Bladder cancer (66)
Brain cancer (19)
Breast cancer (241)
Cancer (1717)
Cardiovascular disease (124)
Career advice (331)
Career pathing (19)
CAR-T (104)
CDC (13)
Cell therapy (243)
Cervical cancer (19)
Clinical research (25568)
Collaboration (445)
Company closure (2)
Compensation (76)
Complete response letters (17)
COVID-19 (1395)
CRISPR (28)
C-suite (221)
Cystic fibrosis (45)
Data (1707)
Decentralized trials (1)
Denatured (4)
Depression (40)
Diabetes (154)
Diagnostics (2991)
Digital health (9)
Diversity (3)
Diversity, equity & inclusion (13)
Drug discovery (68)
Drug pricing (68)
Drug shortages (15)
Duchenne muscular dystrophy (80)
Earnings (21499)
Editorial (32)
Employer branding (5)
Employer resources (39)
Events (20798)
Executive appointments (396)
FDA (5657)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (3)
Frontotemporal dementia (5)
Funding (431)
Gene editing (75)
Generative AI (12)
Gene therapy (219)
GLP-1 (412)
Government (1573)
Grass and pollen (2)
Guidances (139)
Healthcare (5297)
HIV (15)
Huntington's disease (17)
IgA nephropathy (25)
Immunology and inflammation (113)
Immuno-oncology (9)
Indications (20)
Infectious disease (1478)
Inflammatory bowel disease (51)
Inflation Reduction Act (4)
Influenza (28)
Intellectual property (59)
Interviews (82)
IPO (4240)
IRA (23)
Job creations (1044)
Job search strategy (258)
Kidney cancer (8)
Labor market (22)
Layoffs (257)
Leadership (11)
Legal (1445)
Liver cancer (34)
Longevity (3)
Lung cancer (262)
Lymphoma (134)
Machine learning (13)
Management (14)
Manufacturing (187)
MASH (56)
Medical device (3268)
Medtech (3274)
Mergers & acquisitions (4647)
Metabolic disorders (436)
Multiple sclerosis (56)
NASH (12)
Neurodegenerative disease (105)
Neuropsychiatric disorders (25)
Neuroscience (1470)
NextGen: Class of 2025 (1612)
Non-profit (1384)
Now hiring (3)
Obesity (241)
Opinion (142)
Ovarian cancer (54)
Pain (48)
Pancreatic cancer (82)
Parkinson's disease (105)
Partnered (8)
Patents (103)
Patient recruitment (105)
Peanut (19)
People (16240)
Pharmaceutical (3)
Pharmacy benefit managers (10)
Phase I (8044)
Phase II (11431)
Phase III (9024)
Pipeline (1172)
Policy (98)
Postmarket research (711)
Preclinical (2702)
Press Release (28)
Prostate cancer (78)
Psychedelics (16)
Radiopharmaceuticals (109)
Rare diseases (253)
Real estate (1415)
Recruiting (13)
Regulatory (6636)
Reports (12)
Research institute (986)
Resumes & cover letters (43)
Rett syndrome (5)
RNA editing (9)
RSV (29)
Schizophrenia (52)
Series A (80)
Series B (57)
Service/supplier (1)
Sickle cell disease (24)
Special edition (7)
Spinal muscular atrophy (87)
Sponsored (13)
Startups (1482)
Stomach cancer (7)
Supply chain (19)
Tariffs (50)
The Weekly (17)
Vaccines (414)
Venture capital (40)
Weight loss (169)
Women's health (17)
Worklife (6)
Date
Today (28)
Last 7 days (164)
Last 30 days (717)
Last 365 days (11331)
2025 (7872)
2024 (11903)
2023 (13197)
2022 (16113)
2021 (16894)
2020 (15866)
2019 (12181)
2018 (9472)
2017 (9517)
2016 (8515)
2015 (9587)
2014 (6452)
2013 (4774)
2012 (5213)
2011 (5505)
2010 (4806)
Location
Africa (215)
Alabama (19)
Alaska (1)
Arizona (44)
Arkansas (3)
Asia (11276)
Australia (2254)
California (2947)
Canada (769)
China (324)
Colorado (96)
Connecticut (112)
Delaware (93)
Europe (27616)
Florida (379)
Georgia (69)
Idaho (7)
Illinois (207)
India (19)
Indiana (125)
Iowa (5)
Japan (102)
Kansas (39)
Kentucky (3)
Louisiana (3)
Maine (12)
Maryland (309)
Massachusetts (2179)
Michigan (61)
Minnesota (93)
Mississippi (1)
Missouri (26)
Montana (4)
Nebraska (8)
Nevada (31)
New Hampshire (36)
New Jersey (869)
New Mexico (12)
New York (861)
North Carolina (286)
Northern California (1407)
Ohio (63)
Oklahoma (7)
Oregon (12)
Pennsylvania (541)
Puerto Rico (7)
Rhode Island (9)
South America (241)
South Carolina (4)
Southern California (1108)
Tennessee (21)
Texas (559)
United States (10272)
Utah (92)
Virginia (52)
Washington D.C. (23)
Washington State (221)
West Virginia (1)
Wisconsin (38)
179,818 Results for "earli".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Arcturus Prunes Early-Stage Pipeline, Leans Into mRNA Therapies
Arcturus is extending its cash runway into 2028 by discontinuing its early-stage vaccine candidates.
May 14, 2025
·
2 min read
·
Tristan Manalac
Opinion
Evolving Market Pressures Force Biopharma Companies to Cut Assets Early
From a higher bar for regulatory clearance to pricing limitations, drug development is more expensive than ever. This has led firms to make tough pipeline decisions early in the development process. The result may be costly for all of us.
May 21, 2025
·
5 min read
·
Michael N. Abrams
Press Releases
IQVIA Announces CFO Transition in Early 2026
September 3, 2025
·
4 min read
Press Releases
BioMark Diagnostics Announces Landmark Publication Validating High Specificity and Accuracy of Its Early-Stage Lung Cancer Test
Study Published in a special issue of International Journal of Molecular Sciences Confirms Test’s Ability to Distinguish Early Lung Cancer from Other Non-Cancerous Lung Diseases
May 12, 2025
·
4 min read
Manufacturing
Drugmakers Hail Early Wins in AI-Driven Transformation of Manufacturing
Companies have claimed improvements to yield, batch consistency and output while acknowledging the risks and challenges created by the technology.
August 26, 2025
·
5 min read
·
Nick Paul Taylor
Press Releases
Echosens and Novo Nordisk Advance Partnership to Increase Awareness and Early Diagnosis of MASH
August 18, 2025
·
3 min read
Press Releases
Mercy BioAnalytics Announces $59 Million Series B Financing to Advance Early Cancer Detection Programs
September 4, 2025
·
2 min read
Press Releases
Scryb Inc. Provides Early Warning Update on Holdings In Cybeats Technologies Corp.
August 11, 2025
·
4 min read
Obesity
Roche Drops Early Obesity Asset, Citing Lack of Competitiveness
Roche obtained CT-173, a PYY mimetic, in its $2.7 billion acquisition of Carmot Therapeutics in December 2023. The company reported the change in its second quarter earnings call.
July 24, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Cognition Therapeutics Study of Zervimesine (CT1812) in Early Alzheimer’s Disease Reaches 75% Enrollment Target
September 3, 2025
·
7 min read
1 of 17,982
Next
